Business Weekly - Cambridge, UK

Lab-on-a-chip specialist, Dolomite has appointed Insta BioAnalytik in Singapore to take its cutting edge microfluidics technology into the growing Asian biotech region with the aim of developing greater customer relations in the area.

“This appointment reflects the increasing level of interest that we are experiencing around the world from customers interested in working with us to help develop a whole new generation of instruments based on microfluidic technology,” said Dolomite’s commercial director, Gillian Davis.

Dolomite has grown to become a world leader in the field of microfluidics, technology which enables instrument manufacturers to develop smaller, more cost-effective and more powerful analysis systems using very small-scale fluid control.

Using its expertise in microfabrication and microfluidics, Dolomite has recently developed its Micro Mixer chip, a device which enables the rapid and realtime analysis of fluids.

Originally developed for dilution of samples prior to UV analysis, it has also been supplied to customers for nanoparticle synthesis where rapid mixing is important to achieve uniform size or surface properties of nanoparticles, and Dolomite is using its flagship technology to make headway into the emerging Singaporean market.

The company uses a number of futuristic techniques, including photolithography, micro-drilling of fluid ports, and thermal bonding in its microfabrication techniques, capable of creating microchannels and complex structures in the glass. Its technology enables providers in fields as diverse as environmental monitoring, drug discovery and forensic science to deliver microfluidic systems to the market place, which it sees expanding into SE Asia.

“We aim to introduce the latest technologies to the scientific community in Singapore,” said Judy Lim, managing director of Insta BioAnalytik.

“Forming this partnership with Dolomite, a market leader in microfluidic technologies, has allowed us to become an active participant in advancing microfluidic development.”